×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Modératrice :
Pr Isabelle Ray-Coquard

Orateurs :
Dr Maria Selloua
Dr Olivia Le Saux
Dr Coriolan Lebreton

Épisode 2 : Découvrez le programme

 

13:00 Introduction
 
13:05 Cas clinique #1 : Carcinosarcome débutant, en récidive précoce après CR adjuvante Carbo Taxol, Maria Selloua
- Rappel possibilité inclusion essai RAINBO, Colorian Lebreton
- Quelle proposition thérapeutique (ROCSAN)
 
13:20 Cas clinique #2 : K endomètre NSMP M+ d'emblée. Récidive <12 mois après Carbo Taxol et IO
- Quelles options thérapeutiques, Olivia Le Saux
 
13:35 Débat/Discussion et réponses aux questions
Olivia Le Saux, Coriolan Lebreton & Isabelle Ray-Coquard
 

Ne manquez pas les prochaines sessions sur la prise en charge du cancer de l'endomètre avancé !

Épisode 3 Cancer de l'endomètre avancé pMMR P53 muté
RDV le 9 avril 2025 13h
 
Épisode 4 Cancer de l'endomètre avancé pMMR NSMP
RDV le 29 avril 2025 13h
 

 

Shooting date : 2025-03-26
Last update : 2025-04-04

Suggestions

0
Days
0
Hours
0
Minutes
0
Seconds
Tuesday, September 16th 2025 from 06pm to 07:30pm (GMT+2)
Honolulu : Tuesday, September 16th 2025 from 06am to 07:30am (GMT+2)
San Francisco : Tuesday, September 16th 2025 from 09am to 10:30am (GMT+2)
New York : Tuesday, September 16th 2025 from 12pm to 01:30pm (GMT+2)
Buenos Aires : Tuesday, September 16th 2025 from 01pm to 02:30pm (GMT+2)
Reykjavik : Tuesday, September 16th 2025 from 04pm to 05:30pm (GMT+2)
London / Dublin : Tuesday, September 16th 2025 from 05pm to 06:30pm (GMT+2)
Paris / Berlin : Tuesday, September 16th 2025 from 06pm to 07:30pm (GMT+2)
Istanbul : Tuesday, September 16th 2025 from 07pm to 08:30pm (GMT+2)
Moscou / Dubaï : Tuesday, September 16th 2025 from 08pm to 09:30pm (GMT+2)
Bangkok : Tuesday, September 16th 2025 from 11pm to 12:30am (GMT+2)
Shanghai : Wednesday, September 17th 2025 from 12am to 01:30am (GMT+2)
Tokyo : Wednesday, September 17th 2025 from 01am to 02:30am (GMT+2)
Sydney : Wednesday, September 17th 2025 from 03am to 04:30am (GMT+2)
Wellington : Wednesday, September 17th 2025 from 05am to 06:30am (GMT+2)

Cancer de l'ovaire : nouveautés en première ligne

Tuesday, September 19th 2023 from 06pm to 07:30pm (GMT+2)
Honolulu : Tuesday, September 19th 2023 from 06am to 07:30am (GMT+2)
San Francisco : Tuesday, September 19th 2023 from 09am to 10:30am (GMT+2)
New York : Tuesday, September 19th 2023 from 12pm to 01:30pm (GMT+2)
Buenos Aires : Tuesday, September 19th 2023 from 01pm to 02:30pm (GMT+2)
Reykjavik : Tuesday, September 19th 2023 from 04pm to 05:30pm (GMT+2)
London / Dublin : Tuesday, September 19th 2023 from 05pm to 06:30pm (GMT+2)
Paris / Berlin : Tuesday, September 19th 2023 from 06pm to 07:30pm (GMT+2)
Istanbul : Tuesday, September 19th 2023 from 07pm to 08:30pm (GMT+2)
Moscou / Dubaï : Tuesday, September 19th 2023 from 08pm to 09:30pm (GMT+2)
Bangkok : Tuesday, September 19th 2023 from 11pm to 12:30am (GMT+2)
Shanghai : Wednesday, September 20th 2023 from 12am to 01:30am (GMT+2)
Tokyo : Wednesday, September 20th 2023 from 01am to 02:30am (GMT+2)
Sydney : Wednesday, September 20th 2023 from 03am to 04:30am (GMT+2)
Wellington : Wednesday, September 20th 2023 from 05am to 06:30am (GMT+2)

Prise en charge des carcinomes séreux de bas grade en 2023

Share
Monday, September 25th 2023 from 06:30pm to 08pm (GMT+2)
Honolulu : Monday, September 25th 2023 from 06:30am to 08am (GMT+2)
San Francisco : Monday, September 25th 2023 from 09:30am to 11am (GMT+2)
New York : Monday, September 25th 2023 from 12:30pm to 02pm (GMT+2)
Buenos Aires : Monday, September 25th 2023 from 01:30pm to 03pm (GMT+2)
Reykjavik : Monday, September 25th 2023 from 04:30pm to 06pm (GMT+2)
London / Dublin : Monday, September 25th 2023 from 05:30pm to 07pm (GMT+2)
Paris / Berlin : Monday, September 25th 2023 from 06:30pm to 08pm (GMT+2)
Istanbul : Monday, September 25th 2023 from 07:30pm to 09pm (GMT+2)
Moscou / Dubaï : Monday, September 25th 2023 from 08:30pm to 10pm (GMT+2)
Bangkok : Monday, September 25th 2023 from 11:30pm to 01am (GMT+2)
Shanghai : Tuesday, September 26th 2023 from 12:30am to 02am (GMT+2)
Tokyo : Tuesday, September 26th 2023 from 01:30am to 03am (GMT+2)
Sydney : Tuesday, September 26th 2023 from 03:30am to 05am (GMT+2)
Wellington : Tuesday, September 26th 2023 from 05:30am to 07am (GMT+2)

Les scores indispensables dans la prise en charge des cancers de l'ovaire

Cycle d'enseignement - Les cancers gynécologiques

Share
Tuesday, September 5th 2023 from 06:30pm to 08pm (GMT+2)
Honolulu : Tuesday, September 5th 2023 from 06:30am to 08am (GMT+2)
San Francisco : Tuesday, September 5th 2023 from 09:30am to 11am (GMT+2)
New York : Tuesday, September 5th 2023 from 12:30pm to 02pm (GMT+2)
Buenos Aires : Tuesday, September 5th 2023 from 01:30pm to 03pm (GMT+2)
Reykjavik : Tuesday, September 5th 2023 from 04:30pm to 06pm (GMT+2)
London / Dublin : Tuesday, September 5th 2023 from 05:30pm to 07pm (GMT+2)
Paris / Berlin : Tuesday, September 5th 2023 from 06:30pm to 08pm (GMT+2)
Istanbul : Tuesday, September 5th 2023 from 07:30pm to 09pm (GMT+2)
Moscou / Dubaï : Tuesday, September 5th 2023 from 08:30pm to 10pm (GMT+2)
Bangkok : Tuesday, September 5th 2023 from 11:30pm to 01am (GMT+2)
Shanghai : Wednesday, September 6th 2023 from 12:30am to 02am (GMT+2)
Tokyo : Wednesday, September 6th 2023 from 01:30am to 03am (GMT+2)
Sydney : Wednesday, September 6th 2023 from 03:30am to 05am (GMT+2)
Wellington : Wednesday, September 6th 2023 from 05:30am to 07am (GMT+2)

Les nouveaux enjeux de la prise en charge du cancer de l’ovaire en première ligne : L’exemple d...

Cycle d'enseignement sur le cancer de l'ovaire - Première session

Share
Scroll Up